Cian Healthcare Ltd
Cian Healthcare Ltd (CHCL): company summary
The company's business is deteriorating, with annual revenue falling 8.1% to ₹28 crore and annual net profit turning from a loss of ₹26 crore to a loss of ₹23 crore.
Cian Healthcare Ltd (CHCL) is a micro-cap Healthcare company valued at ₹84 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Cian Healthcare Ltd last traded at ₹33.49, modestly up 1.98% on the day.
- Financial performance
- The company's business is deteriorating, with annual revenue falling 8.1% to ₹28 crore and annual net profit turning from a loss of ₹26 crore to a loss of ₹23 crore. The latest quarter saw revenue rise 41.7% year-on-year to ₹17 crore, but the net loss widened to ₹18 crore from ₹8 crore, indicating persistent cost pressures.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 7.17 times book value.
- Things to watch
- The company is highly leveraged with debt to equity at 3.36, and reported a net loss of ₹23 crore in its latest financial year. The stock is 74.9% below its 52-week high, and the net profit margin improved only slightly to -82.3%.
- Where it stands
- The company remains in a net loss position with a high debt to equity ratio and a stock price far below its 52-week high. The most significant movement was the widening net loss in the latest quarter, which highlights ongoing challenges in profitability.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Key numbers
Price-based figures are live; statement figures are from FY26, consolidated where filed.
Valuation
- Market cap
- ₹84 Cr
- P/E
- —
- P/B
- 7.2×
- P/S
- —
- EV/EBITDA
- —
- Earnings yield
- —
- Dividend yield
- —
- Fair value
Profitability
- ROE
- -49.2%
- ROCE
- -61.7%
- ROIC
- -47.8%
- ROA
- -37.8%
- Gross margin
- 20.4%
- Operating margin
- -24.5%
- Net margin
- -82.3%
- EPS (TTM/FY)
- ₹-9.32
Growth
- Sales · last qtr YoY
- —
- Profit · last qtr YoY
- —
- Sales · 1Y
- −8.1%
- Profit · 1Y
- +10.4%
- Sales CAGR · 3Y / 5Y
- −26% / −17%
- Profit CAGR · 3Y / 5Y
- — / —
- EPS CAGR · 5Y
- —
- Sales CAGR · 10Y
- —
Balance sheet
- Debt / equity
- 3.36
- Net debt / EBITDA
- -3.97×
- Interest cover
- -107.1×
- Current ratio
- 0.78
- Total debt
- ₹29 Cr
- Cash
- ₹1 Cr
- Book value / share
- ₹3.4
- Free cash flow
- ₹12 Cr
Quality & trading
- Piotroski F-score
- 4 / 9
- Altman Z
- -2.58
- Cash conversion cycle
- 26 days
- Dividend payout
- 0%
- Delivery %
- 100.0%
- Volume vs 30D avg
- 0.37×
- Avg traded value
- ₹0 Cr/day
- Face value
- ₹10.00
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Cian Healthcare Ltd’s valuation
Free deep-dive tools · no sign-up
Cian Healthcare Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Cian Healthcare Ltd with peers
Related tools & concepts
Value Cian Healthcare Ltd with the ratios and calculators DocStoX uses in its analysis.

